Delivery Order SPE2DB20D1109-SPE2DB23FP24P
Award Date
6/1/23
Potential Completion Date
6/2/23
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,666.36 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major federal agency customer for Amerisourcebergen. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,805.87 firm fixed price delivery order contract has a completion date of May 2, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,587.81 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on October 14, 2021, with an ultimate completion date of October 15, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the pharmaceutical product Dupixent 200 mg/1.14 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office division. The $3,215.43 firm-fixed-price delivery order was issued by the Defense agency Medical Supply Chain, with a performance location in Conshohocken, Pennsylvania. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA)...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $31,697.12 firm-fixed-price delivery order has a completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,441.69 and a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, valued at $21,554.12, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a firm-fixed price delivery order with an ultimate completion date of August 1, 2024. This award is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $9,655.91 firm fixed-price delivery order is for the supply of the medication Dupixent (300 mg/2 ml pen, 2 ml) to DLA facilities. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The $19,637.94 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 14, 2023 with an ultimate completion date of June 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,213.76, is for the delivery of Dupixent 300 mg/2 ml pen, a specialty medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC...